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Mesenchymal Stem Cells Improve Wound Healing In Vivo via 
Early Activation of Matrix Metalloproteinase-9 and Vascular 
Endothelial Growth Factor
We investigated the effects of mesenchymal stem cells (MSCs) on wound healing using a 
three-dimensional (3D) collagen gel scaffold. Three circular full-thickness skin defects were 
created on the back of Sprague-Dawley rats. One site was covered with a 3D collagen gel 
containing 2 × 10
6 MSCs (MSCs+/3D collagen+). Another site was replaced with a 3D 
collagen gel without MSCs and the third site was left empty. The wound size was 
significantly reduced in the MSCs+/3D collagen+ sites. MSCs+/3D collagen+ sites exhibited 
the most neovascularization. FISH showed that Y-chromosome possessing cells were found 
within the dermis of MSCs+/3D collagen+ sites. Gelatin zymography revealed that the 
most intense expression of MMP-9 was detected early in the MSCs+/3D collagen+ sites. 
Our results indicate that MSCs upregulate the early expression of MMP-9 which induces 
the early mobilization of VEGF. Thus, MSCs appear to accelerate significantly wound 
healing via early activation of MMP-9 and VEGF.
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INTRODUCTION
Wound healing requires the complex biomolecular processes of 
cell migration, proliferation, angiogenesis, and extracellular ma-
trix remodeling (1, 2). This process involves various cells, growth 
factors, and the extracellular matrix (ECM). During wound heal-
ing, cell migration and tissue remodeling necessitate degrada-
tion of ECM and release of growth factors (3). The proteolytic 
degradation of ECM is achieved by extracellular proteases in-
volving the matrix metalloproteinases (MMPs). These MMPs, 
particularly MMP-9, are thought to play a critical role in degrad-
ing ECM to facilitate the necessary initial steps for angiogenesis. 
The high expression of MMPs stimulates the angiogenic response, 
subsequently promoting the process of wound healing. 
  Angiogenesis is subjected to a complex control system with 
pro-angiogenic and anti-angiogenic factors. One of the most 
important pro-angiogenic factors is vascular endothelial growth 
factor (VEGF). During the early period of wound healing, angio-
genic capillary sprouts penetrate into the provisional matrix and 
create microvascular networks (2). Neovascularizaton involves 
the dynamic interactions of cells, growth factors, and the matrix. 
VEGF stimulates and increases neovascularization.
  Bone marrow-derived mesenchymal stem cells (BM-MSCs) 
have the capacity to differentiate along three essential mesen-
chymal lineages: osteoblasts, adipocytes, chondroblasts (4, 5). 
Also, BM-MSCs can express the phenotypic genes of hepato-
cytes, cardiomyocytes, astrocytes, neurons, and skin-related tis-
sue (6-10). There have been reports showing wound healing ef-
fectively achieved with the application of BM-MSCs (11, 12). 
However, despite increasing knowledge of MSCs, their contribu-
tion to wound healing is not understood, and many questions 
remain.
  We selected the 3D collagen allograft model, which is most 
similar to the skin dermis structure, to apply rat MSCs in the col-
lagen gel scaffold composed of rat tail type I collagen in an at-
tempt to maintain the functions of stem cells for a prolonged 
period. The objective of our study was to investigate the effects 
of MSCs on wound healing using 3D collagen gel scaffold in vivo. 
MATERIALS AND METHODS
Experimental animal model 
Eighteen adult female Sprague-Dawley rats, weighing 200 g, were 
used at 6 weeks of age. All animal procedures were approved 
under the guidelines approved by the institutional animal care 
and use committee from Soonchunhyang University. This study Kim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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was carried out from March 2006 to May 2007 at the Soonchun-
hyang University. Each rat had free access to both sterile water 
and standard rodent soft chow ad libitum. 
Harvest and culture of MSCs 
The bone marrow was harvested from specific pathogen-free, 
6-week-old male Sprague-Dawley rats (Charles River Technol-
ogy). In brief, the rats were killed, and femurs and tibias were 
removed aseptically. A hole was then created in the knee joint 
end of each bone with a 26-gauge needle, and marrow was 
flush  ed with phosphate buffered saline (PBS, Gibco BRL, Grand 
Island, NY, USA) containing 2% fetal bovine serum (FBS, Gibco 
BRL). The marrow solution was washed by centrifugation at 400 
× g for 5 min. The supernatant was aspirated, and the pellet was 
resuspended in Dulbecco’s modified Eagle’s medium-low glu-
cose (DMEM-LG, Gibco BRL) containing 10% FBS and 1% pen-
icillin-streptomycin (Gibco BRL). Cells were seeded into 75 cm
2 
tissue culture flask and cultured in humidified 5% CO2 incuba-
tor at 37°C for 72 hr. Non-adherent cells were removed. When 
adherent cells reached subconfluence, they were detached with 
0.25% trypsin-EDTA solution, and re-seeded at 2 × 10
3 cells/cm
2. 
The rat MSCs were used for experiments after the passage 5.
Differentiation of MSCs
For osteogenic differentiation of MSCs, MSCs were maintained 
with DMEM medium containing 0.1 μM dexamethasone (Sig-
ma, St. Louis, MO, USA), 50 μM ascorbate (Sigma), 10 mM β- 
glycerol phosphate (Sigma), and 10% FBS for 3 weeks, with the 
increase of calcium examined using Von Kossa staining.
  For adipogenic differentiation of MSCs, MSCs were cultured 
in DMEM medium (Adipogenic induction, MDI + I) containing 
0.1 μM dexamethasone (Sigma), 10 μg/mL insulin (Sigma), 100 
mM indomethacin (Sigma), 0.5 mM methyl-isobuthylxanthine 
(Sigma), and 10% FBS for 72 hr. The medium was changed to 
DMEM medium (Adipogenic maintenance, AM), containing 
insulin (10 μg/mL) and 10% FBS for 24 hr. The cells were then 
re-treated with MDI + I for a second treatment. The cultures were 
then maintained in AM for 1 week before fixation. Adipogenic 
differentiation was demonstrated by the accumulation of lipid 
vesicles with Oil-Red O staining. 
  For chondrogenic differentiation of MSCs, MSCs were treat-
ed with trypsin-EDTA. Then, 2 × 10
5 cells were added to 500 μL 
of DMEM medium containing 10
-7 M dexamethasone (Sigma), 
1 μg/mL TGF-β (R&D Systems, Minneapolis, MN, USA), and 50 
μM ascorbic acid 2-phosphate (Sigma), and centrifuged at 1,000 
rpm for 5 min. The cells were grown as a pelleted micromass for 
3 weeks. The cell pellet was stained with toluidine blue.
 
Flow cytometric analysis of MSCs
MSCs were trypsinized, washed with PBS, and incubated with 
antibodies against fluorescein isothiocyanate (FITC)-conjugat-
ed CD44H (Pgp-1, BD Biosciences Pharmingen), CD90 (Thy-1, 
BD), CD11b (Integrin, BD), phycoerythrin (PE)-conjugated 
CD106 (VCAM-1, BD), and CD45 (BD). Analysis was performed 
with a flow cytometer (Beckman Coulter, Inc., CA, USA).
Preparation of the three-dimensional collagen gel scaffold
Collagen gel scaffolds were prepared in a sterile tube, by mixing 
an appropriate volume of rat tail type I collagen (BD Biosciences) 
to yield a final concentration of 1 mg/mL with medium cocktail 
(DMEM, NaHCO3 [44 mM/L], L-glutamine [4 mM/L], and folic 
acid [9 mM/L], neutralized with 1N NaOH to pH 7.2). Collagen 
solution (1 mL per well of a 6-well plate) was placed in an incu-
bator at 37°C for 30 min to allow polymerization of the collagen. 
Assembly of stem cell/collagen tissue construct implants 
Control scaffolds were prepared as above. Early passage prima-
ry rat MSCs (2 × 10
6/well) were placed on top of each collagen 
scaffold and allowed to attach. After attachment, collagen scaf-
folds were covered with 1 mL of media (DMEM, 10% FBS) and 
incubated for 72 hr at 37°C, and 5% CO2. The circular MSCs/3D 
collagen gel scaffolds, at a density of 2 × 10
6 cells for implanta-
tion, were 20-mm diameter. 
Surgical procedures 
In an aseptic surgical room, the rats were anesthetized with in-
traperitoneal ketamine (60 mg/kg) and xylazine (8 mg/kg). After 
induction of general anesthesia, the dorsal regions of the rats 
were shaved. The dorsal skin was disinfected with 10% povidone-
iodine and 70% alcohol. Three circular full-thickness defects 
20-mm in diameter, including the panniculus carnosus muscle, 
were created on the back of each rat. One site was covered with 
3D collagen gel containing 2 × 10
6 male rat MSCs (MSCs+/3D 
collagen+ site). Another site replaced with 3D collagen gel with-
out MSCs (MSCs-/3D collagen+) and the third site was left empty 
(MSCs-/3D collagen-). All wounds were covered with a sterile 
transparent silicone membrane (Tegaderm, 3M Health Care, St. 
Paul, MN, USA) to prevent desiccation. Each animal was then 
housed in its own cage to avoid damage of the wound. Digital 
pictures were taken to visualize the wound. Wound healing was 
calculated based on the remaining wound area.
  The rats were sacrificed with an overdose of sodium pento-
barbital at either 3, 7, 14, or 21 days after wounding. Full-thick-
ness wound tissues, including the adjacent skin, were then har-
vested, fixed immediately in 10% formalin for 12 hr, embedded 
in paraffin and sliced into 6-micrometer-thick sections for sub-
sequent immunohistochemistry. For positive controls, normal 
healthy rat tissues were harvested. 
Measurement of wound size
The wound sizes in a standard prone position were photographed 
using a 334 million d.p.i. digital camera (Canon) and an image Kim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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analyzer (Image Pro Plus, ver. 5.1; Media Cybernetics) on a per-
sonal Microsoft computer. The macroscopic sizes of the remain-
ing wounds were calculated three times for each animal at 0, 3, 
7, 14, and 21 days after initial wounding. 
Immunohistochemical staining
Paraffin sections were deparaffinized with xylene, rehydrated 
with 10 mM citrate buffer (pH 6.0) solution, and then treated in 
a microwave oven for 15 min to restore antigens. To suppress the 
reaction of endogenous peroxidase within the tissues, the sam-
ples were treated with 3% peroxide for 5 min and then with a 
blocking solution for 30 min. Slides were then placed in a hu-
mid chamber and incubated for 60 min with the anti-VEGF an-
tibody (sc-152; Santa Cruz Biotec., Santa Cruz, CA, USA). Tissue 
staining was visualized with a 3,3´-diaminobenzidine (ACK500; 
ScyTek, Logan, UT, USA) substrate chromogen solution.
Gelatin zymography 
Protein samples (20 μg of protein) were mixed with 2× sample 
buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.0025 
bromphenol blue) and added to the gel without boiling. MMP-2 
and MMP-9 activities were analyzed using 10% zymogram gel-
atin gel (EC6175Box, Invitrogen). Following electrophoresis, gels 
were washed twice, first with a 1 × renaturing buffer (1 M Tris-
HCl [pH 7.4], Triton X-100) for 30 min, after the gel was washed 
with distilled water for 30 min. Next, gels were reacted with a 1× 
developing buffer (50 mM Tris base, 40 mM HCl, 200 mM NaCl, 
5 mM CaCl2, 0.02% [w/v] Brij35) for 30 min, by incubating over-
night at 37°C. Gels were treated with 0.5% Coomassie blue R-250 
in destaining solution (40% ethanol, 8% acetic acid) for 3 hr and 
destained in the same solution without Coomassie blue. 
X and Y chromosome fluorescence in situ hybridization 
X and Y chromosome fluorescence in situ hybridization (FISH) 
was performed in frozen tissues in order to confirm the existence 
of stem cells. Probes for rat DNA (ID Labs Inc.) were applied. 
Briefly, six-micrometer thick frozen tissue sections were rehy-
drated for 5 min each in 100% EtOH, 90% EtOH, and 70% EtOH, 
and washed in 4 × standard saline citrate (SSC)/0.5% Tween 20 
for 30 min in rotating shaker. Pre-fixated slides were incubated 
in a solution of protease (32-801260, VYSIS
TM) for 20 min at 37°C, 
and washed in PBS, PBS/MgCl2, and formaldehyde/PBS/MgCl2. 
Slides were dehydrated in 70%, 90%, and 100% EtOH and dried 
in air. Ten μL probe was dropped onto the slide, and sealed with 
a cover slip and rubber cement. Pre-treated sections and probes 
were denatured at 80°C for 5 min and incubated in an incubator 
for 4 hr at 37°C. Post-hybridization washes were performed for 
2 min in a 0.4 × SSC solution and 30 sec in 2 × SSC/0.05% Tween 
20. Tissue sections were counter-stained with 7 μL of 4´,6-diamid-
ino-2-phenylindole (DAPI). Results were analyzed under a flu-
orescent microscope and VYSIS
TM direct-labeled FISH probe 
(VYSIS
TM, USA). 
Statistical analyses 
Data were evaluated by analysis of variance (Stacel, add-in soft-
ware to Microsoft
® Excel 2000). Statistical analyses were per-
formed using the one-way ANOVA followed by Scheffé’s multi-
ple-comparison test, and P value of less than 0.05 was consid-
ered statistically significant. 
RESULTS
Characterization of cultured rat MSCs
When cultured in osteogenic, chondrogenic, and adipogenic 
medium, they differentiated into osteocytes, chondrocytes, and 
adipocytes (Fig. 1). Flow cytometer analysis confirmed expres-
sion of stem cell-related surface markers. Cultured adherent cells 
expressed CD44H and CD90, but not hematopoietic markers 
such as CD11b, CD45, and CD106 (Fig. 2). Thus, we confirmed 
that the adherent cells were mesenchymal stem cells.
Wound size measurements 
Each experimental site was relatively of the same size at day 3 
due to excision of the panniculus carnosus muscle. The most 
effective wound healing was observed at day 7 (Fig. 3). At day 7, 
the wound size of MSCs+/3D collagen+ sites was significantly 
decreased (0.48 ± 0.01 cm
2: P < 0.05), which were significantly 
smaller than the MSCs-/3D collagen- sites (0.92 ± 0.01 cm
2) or 
A B C
Fig. 1. Characterization of MSCs in vitro. Differentiation of MSCs. (A) Cultured in appropriate differentiate media, MSCs differentiated osteocytes. (B) Chondrocytes in pellet cul-
ture which were positive for toluidine blue. (C) Adipocytes were demonstrated by the accumulation of lipid vesicles with oil red O staining (original magnification, × 40). Kim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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the MSCs-/3D collagen- sites (0.66 ± 0.02 cm
2). Also, there was 
no significant difference between MSCs-/3D collagen+ sites and 
MSCs-/3D collagen- sites (Fig. 4). MSCs+/3D collagen+ sites 
demonstrated accelerated wound healing. Since there was a pos-
sibility that the rate of wound healing could vary with the defect 
position, we repeated the same procedure by changing the po-
sitions of the defect sites, which yielded similar results.
Immunohistochemistry 
The tissue samples from each experimental group at day 7, when 
stained with VEGF antibody, showed that MSCs+/3D collagen+ 
sites exhibited the most distinct neovascularization compared 
to other sites (Fig. 5).
X and Y chromosome fluorescence in situ hybridization 
Y-chromosomes were probed with spectrum red (Cy3), where-
as X-chromosomes with spectrum green (FITC). FISH analysis 
showed that many Y-chromosome positive cells were identified 
within the dermis of MSCs+/3D collagen+ sites at day 7 (Fig. 6). 
Gelatin zymography
We used the gelatin zymography to assess the expression status 
of MMP-2 (72-kDa/gelatinase A) and MMP-9 (92-kDa/gelatin-
ase B). MMP-2 was expressed in all experimental sites, includ-
ing normal rat skin tissue, at day 3 and day 7. MMP-9 was not 
detected in normal tissue, but expressed in MSCs-/3D collagen+ 
sites, MSCs-/3D collagen- sites, and MSCs+/3D collagen+ sites. 
Interestingly, MMP-9 was expressed most intensively early in 
MSCs+/3D collagen+ sites at day 3. However, by day 7, MMP-9 
was weakly expressed in MSCs+/3D collagen+ sites compared 
to MSCs-/3D collagen+ and MSCs-/3D collagen- sites (Fig. 7). 
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Fig. 2. Flow cytometer analysis of rat 
mesenchymal stem cells. MSCs were 
analyzed by flow cytometer after stain-
ing with FIFC- or PE-conjugated anti-
bodies against indicated cell surface 
proteins. MSCs did not produce CD11b, 
CD45, CD106 antigens, but produced 
CD44H, CD90 antigens.
Fig. 3. Effects of MSCs. The wound size was significantly smaller in the MSCs+/3D 
collagen+ site at day 7. 
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Fig. 4. Wound size measurement. MSCs+/3D collagen+ sites were significantly de-
creased (0.48 ± 0.01 cm
2: *P < 0.05), which were significantly smaller than the 
MSCs-/3D collagen+ sites (0.92 ± 0.01 cm
2) or MSCs-/3D collagen- sites (0.66 ± 
0.02 cm
2). Kim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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DISCUSSION
Wound healing is a complex process requiring the proper ex-
pression of signaling molecules and receptors, cellular adhesion 
molecules, and ECM proteins. These molecules are processed 
by MMPs and regulate many processes of wound healing (13). 
A B
C D
Fig. 5. Immunohistochemistry. VEGF was not detected in the normal rat skin tissue. The MSCs+/3D collagen+ site was showed the most expression of VEGF than MSCs-/3D 
collagen+ site and MSCs-/3D collagen- site (A, Normal rat skin; B, MSCs-/3D collagen+ site; C, MSCs-/3D collagen- site; D, MSCs+/3D collagen+ site; A to D, × 400 mag-
nification). 
A B
Fig. 6. Fluorescence in situ hybridization. (A) Positive control. Probe (Whole chromosome Painting Probe): Rat X/Y (FITC/Cy3) Probe. (B) Y-chromosome positive cells were iden-
tified within the dermis of MSCs+/3D collagen+ site at day 7. Y-chromosomes were probed with spectrum red (Cy3), X-chromosomes with spectrum green (FITC).
MMPs contribute too many aspects of tissue regeneration and 
angiogenesis by promoting the release of ECM-bound cytokines 
or angiogenesis-modulating ECM fragments (14). Recent stud-
ies have reported that implanted MSCs accelerate the restora-
tion of damaged tissue (15-17). With regard to tissue regenera-
tion, this potency of MSCs may play a more principal role than 
X
YKim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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trans-differentiation (18). In the present study, MSCs+/3D col-
lagen+ sites significantly reduced the wound size and exhibited 
the most intense expression of VEGF. VEGF is a potent angio-
genic factor that stimulates angiogenesis in vivo (19-21). Angio-
genesis is a complex and dynamic process which is affected by 
many factors including growth factors, cytokines, and ECM (22). 
The expression of VEGF is thought to be potentiated in response 
to the activation of bioactive molecules, and VEGF is considered 
to mediate angiogenic activity during the early period of wound 
healing.
  There are interesting differences between MMP-2 and MMP-
9 by gelatin zymography. MMP-2 was expressed in all experi-
mental sites including normal rat skin tissue. This finding indi-
cates that MMP-2 plays a less important role in early tissue me-
tabolism. MMP-9 was expressed in MSCs+/3D collagen+ sites, 
MSCs-/3D collagen+ sites, and MSCs-/3D collagen+ sites, but 
not in normal rat skin tissue. Interestingly, during the early heal-
ing period (day 3), MMP-9 was most intensively expressed in 
MSCs+/3D collagen+ sites. In the later period (day 7), however, 
MMP-9 was more weakly expressed in MSCs+/3D collagen+ 
sites, compare to MSCs-/3D collagen+ sites and MSCs-/3D col-
lagen- sites. This suggests that MMP-9 is involved in the early 
period of wound healing which coincides with enhanced wound 
healing process via angiogenesis. This is in good agreement with 
the findings that many processes are involved in the early peri-
od of wound healing require the action of proteases to facilitate 
cell movement, tissue degradation, granulation tissue formation 
and angiogenesis (1, 2). Hence, MMP-9, which is expressed ear-
ly in MSCs+/3D collagen+ sites, appears to play critical roles in 
initiating angiogenesis.
  There are reports that MMP-9, but not MMP-2, stimulates the 
production and secretion of VEGF in retinal pigment epithelial 
cells (23), and that inhibition of MMP-9 attenuates VEGF-in-
duced intracerebral hemorrhage (24). Upon secretion, VEGF 
becomes bound to the ECM (25), and the interaction of VEGF 
with ECM proteins is mediated via ECM-binding domain. VEGF 
is encoded by a single gene and the coding portion contains 
eight exons (26). Exon 6 and 7 have been demonstrated to en-
code the ECM-binding domain of the protein. This domain can 
bind matrix proteins and is considered to account for the seques-
tration of VEGF within the ECM (27, 28). Thus, VEGF becomes 
liberated by ECM degradation through MMPs. Their effects are 
due to the mobilization of VEGF release through the degrada-
tion of ECM proteins by MMPs. In this study, VEGF and MMP 
were expressed in MSCs+/3D collagen+ sites. These factors may 
have an effect in a single manner or rather interact with each 
other. Early expressed MMP-9 promotes the release of extracel-
lular matrix-bound cytokines, VEGF, which regulates angiogen-
esis. In the present study, MSCs upregulate the early expression 
of MMP-9, not MMP-2. This early upregulation of MMP-9 seems 
to be the crucial steps in angiogenesis.
  In the present study, we used a three-dimensional collagen 
gel scaffold. In vivo, cells within the tissue are surrounded by 
complex three-dimensional microenvironments. Three-dimen-
sional scaffolds possibly give an appropriate cell density and 
mimic ECM microenvironments in vivo. The main structural 
element of the ECM is collagen type-I which is why 3D collagen 
scaffolds have been frequently used. Up to our knowledge, there 
is no prior study dealing with 3D collagen and MSCs in wound 
healing. The 3D collagen gel scaffold is constitutionally suited, 
therefore, stably introduces MSCs to the experimental sites. 
  There have been reports stating that adult stem cells demon-
strate a low level of engraftment (29, 30). At day 7, within the 
dermis of MSCs+/3D collagen+ sites, we detected Y-chromo-
some possessing cells in FISH and VEGFs were expressed in 
large amounts by immunohistochemistry. These Y-chromo-
some possessing MSCs and increased VEGFs, are expressed 
early in MSCs+/3D collagen+ sites, are most likely to promote 
dermal remodeling, since they were observed in the dermis of 
MSCs+/3D collagen+ sites. MSCs+/3D collagen+ site enhances 
pro-angiogenic properties by early induction of MMP-9 and 
VEGF. 
  In conclusion, early expression of MMP-9 and VEGF, as part 
of an underlying mechanism of accelerated wound healing, play 
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Fig. 7. Gelatin zymography. The level of 
MMP-9 (92-kDa/gelatinase B) was de-
tect early in MSCs+/3D collagen+ site at 
day 3. MMP-2 (72-kDa/gelatinase A) was 
expressed in all experimental sites (HT-
1080, positive control: Human fibrosar-
coma cell line). Kim CH, et al.  •  Mesenchymal Stem Cells Enhance Wound Healing
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crucial roles in increasing angiogenesis and dermal remodeling. 
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Mesenchymal Stem Cells Improve Wound Healing In Vivo via Early Activation of 
Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor
Chul Han Kim, Jang Hyun Lee, Jong Ho Won and Moon Kyun Cho 
We investigated the effects of mesenchymal stem cells (MSCs) on wound healing using a three- dimensional (3D) collagen gel 
scaffold. Full-thickness skin defects in Sprague-Dawley rats were effectively recovered with  neovascularization by MSCs+3D 
collagen. The transplanted MSCs were found within the dermis of wound sites. Gelatin zymography revealed intense expression of 
MMP-9 in the MSCs+3D collagen-treated sites. We suggest that the early expression of MMP-9 and VEGF as part of an underlying 
mechanism of accelerated wound healing by MSCs+3D collagen. 